A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

NCT01050582 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder
Autistic Disorder
Conduct and Other Disruptive Behavior Disorders

Interventions

DRUG: Risperidone
DRUG: Other atypical antipsychotic drugs

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.